Schedule 13G ownership disclosure

VASCULAR BIOGENICS LTD

Security class unavailable · CUSIP: M96883109

Event date: 2018-06-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,904,762
Percent of class
5.3100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000093
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Jun 26, 2018
Reporting period
Jun 25, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub